Virucidal efficacy of a novel silver-based disinfectant against SARS-CoV-2 Omicron BA.5

被引：0
作者：
Zani, Alberto [1 ]
Messali, Serena [1 ]
Caccuri, Francesca [1 ]
机构：
[1] Univ Brescia, Dept Mol & Translat Med, Sect Microbiol, Brescia, Italy
来源：
NEW MICROBIOLOGICA | 2023年 / 46卷 / 01期
关键词：
SARS-CoV-2; Omicron BA; 5; variant; disinfectants; Silver Barrier;
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
In this study we evaluated the antiviral activity of the Silver Barrier (R) disinfectant against SARS-CoV-2. Silver Barrier (R) showed time-and concentration-dependent antiviral activity against SARS-CoV-2. After 5 min contact time, Silver Barrier (R) at 0.002% showed a strong inhibitory effect (p < 0.001), with a 2-fold reduction of viral genome copy numbers, and a robust suppression (94%) of SARS-CoV-2 infectivity. Considering the effects obtained in solution and within a very short time, Silver Barrier (R) stands as an excellent new candidate for the disinfection of work environments, especially at the healthcare level, where there are people at high risk of serious illnesses.
引用
收藏
页码：60 / 64
页数：5
相关论文
共 50 条
  • [41] Efficacy of Peracetic Acid and Sodium Hypochlorite against SARS-CoV-2 on Contaminated Surfaces
    Morris, J. N.
    Esseili, M. A.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2023, 89 (07)
  • [42] Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial
    Branche, Angela R.
    Rouphael, Nadine G.
    Losada, Cecilia
    Baden, Lindsey R.
    Anderson, Evan J.
    Luetkemeyer, Anne F.
    Diemert, David J.
    Winokur, Patricia L.
    Presti, Rachel M.
    Kottkamp, Angelica C.
    Falsey, Ann R.
    Frey, Sharon E.
    Rupp, Richard
    Baecker, Martin
    Novak, Richard M.
    Walter, Emmanuel B.
    Jackson, Lisa A.
    Little, Susan J.
    Immergluck, Lilly C.
    Mahgoub, Siham M.
    Whitaker, Jennifer A.
    Babu, Tara M.
    Goepfert, Paul A.
    Fusco, Dahlene N.
    Atmar, Robert L.
    Posavad, Christine M.
    Netzl, Antonia
    Smith, Derek J.
    Telu, Kalyani
    Mu, Jinjian
    Makowski, Mat
    Makhene, Mamodikoe K.
    Crandon, Sonja
    Montefiori, David C.
    Roberts, Paul C.
    Beigel, John H.
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (04) : 560 - 564
  • [43] The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
    Dapporto, Francesca
    Leonardi, Margherita
    Trombetta, Claudia Maria
    Semplici, Claudia
    Piu, Pietro
    Piccini, Giulia
    Benincasa, Linda
    Marchi, Serena
    Andreano, Emanuele
    Lovreglio, Piero
    Buonvino, Nicola
    Decaro, Nicola
    Stufano, Angela
    Lorusso, Eleonora
    Bombardieri, Emilio
    Ruello, Antonella
    Viviani, Simonetta
    Rappuoli, Rino
    Molesti, Eleonora
    Manenti, Alessandro
    Montomoli, Emanuele
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [44] Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses
    Ijaz, M. Khalid
    Nims, Raymond W.
    Zhou, Sifang Steve
    Whitehead, Kelly
    Srinivasan, Vanita
    Kapes, Tanya
    Fanuel, Semhar
    Epstein, Jonathan H.
    Daszak, Peter
    Rubino, Joseph R.
    McKinney, Julie
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants
    Wang, Rui
    Huang, Xun
    Cao, Tianshu
    Sun, Chunyun
    Luo, Dan
    Qiu, Hongying
    Wu, Mei
    Huang, Xingyao
    Yu, Chulin
    Li, Jing
    Kong, Desheng
    Ma, Juan
    Zhang, Xiao
    Hu, Ping
    Zhang, Yanjing
    Luo, Chunxia
    Zhao, Hui
    Li, Yuchang
    Deng, Yongqiang
    Qin, Chengfeng
    Xie, Liangzhi
    VIROLOGY, 2022, 576 : 61 - 68
  • [46] Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant
    Bekliz, Meriem
    Adea, Kenneth
    Puhach, Olha
    Perez-Rodriguez, Francisco
    Melancia, Stefane Marques
    Baggio, Stephanie
    Corvaglia, Anna-Rita
    Jacquerioz, Frederique
    Alvarez, Catia
    Essaidi-Laziosi, Manel
    Escadafal, Camille
    Kaiser, Laurent
    Eckerle, Isabella
    MICROBIOLOGY SPECTRUM, 2022, 10 (04):
  • [47] SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice
    Ogger, Patricia P.
    Martin, Minerva Garcia
    Jang, Soyeon
    Zhou, Jie
    Brown, Jonathan
    Sukhova, Ksenia
    Furnon, Wilhelm
    Patel, Arvind H.
    Cowton, Vanessa
    Palmarini, Massimo
    Barclay, Wendy S.
    Johansson, Cecilia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [48] SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy
    Singh, Desh Deepak
    Sharma, Anshul
    Lee, Hae-Jeung
    Yadav, Dharmendra K.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [49] Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster
    Zhang, Ya-Nan
    Zhang, Hong-Qing
    Wang, Gui-Feng
    Zhang, Zhe-Rui
    Li, Jia-Qi
    Chen, Xiao-Ling
    Hu, Yan-Yan
    Zeng, Xiang-Yue
    Shi, Yu-Jia
    Wang, Jing
    Li, Ying-Hua
    Li, Xiao-Dan
    Wang, Chun-He
    Zhu, Bing
    Zhang, Bo
    ANTIVIRAL RESEARCH, 2023, 209
  • [50] Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain
    Ying, Baoling
    Liang, Chieh-Yu
    Desai, Pritesh
    Scheaffer, Suzanne M.
    Elbashir, Sayda M.
    Edwards, Darin K.
    Thackray, Larissa B.
    Diamond, Michael S.
    JOURNAL OF VIROLOGY, 2024, 98 (09)
12345